Fulltext

Health resource utilization and the economic burden of patients with wet age-related macular degeneration in Thailand

Dilokthornsakul P 1 , Chaiyakunapruk N 2 , Ruamviboonsuk P 3 , Ratanasukon M 4 , Ausayakhun S 5 , Tungsomeroengwong A 3 Show all authors , Pokawattana N 3 , Chanatittarat C 6

Affiliations 

  • 1 Center of Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand
  • 2 Center of Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand ; Discipline of Pharmacy, Monash University Malaysia, Selangor 46150, Malaysia ; School of Population Health, University of Queensland, Brisbane QLD 4072, Australia ; School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53706, USA
  • 3 Department of Ophthalmology, Rajavithi Hospital, Bangkok 10400, Thailand
  • 4 Department of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand
  • 5 Department of Ophthalmology, Faculty of Medicine, Chiangmai University, Chiangmai 50200, Thailand
  • 6 Novartis (Thailand) Ltd., Bangkok 10110, Thailand
Int J Ophthalmol, 2014;7(1):145-51.
PMID: 24634881 DOI: 10.3980/j.issn.2222-3959.2014.01.27

Abstract

To determine healthcare resource utilization and the economic burden associated with wet age-related macular degeneration (AMD) in Thailand.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications